Key Aspects of Contamination Control Strategy in Vaccine and Biologicals Production
Posted on June 26, 2024
Aqeel Ahmed Soomro, GM Production, Engineering & Warehouse, Kaizen Pharmaceuticals, Pakistan
Introduction To guarantee the consistent production of high-quality biologic products, it’s imperative to establish a robust contamination control strategy (CCS). Given the intricate nature of biologic and vaccine production, which entails the utilization of living cells and intricate processes, t...
To read the full article and other articles in this issue, please register for a free account or log in.
We will not sell or give your information to a third party. See our Privacy Policy
Subscribe to our FREE newsletter and WEBINAR UPDATES
We will not sell or give your information to a third party. See our Privacy Policy